{
    "elements": [
        {
            "Type": "Paragraph",
            "Text": "AABIPEvidence-informedGuidelinesandExpert PanelReportfortheManagementofIndwelling PleuralCatheters RussellJ.Miller,MD,CDR,MC,USN,* \u0192 AraA.Chrissian,MD, \u2044 Y.C.GaryLee,MBChB,PhD,\u00a7 \u0001 \u00b6#NajibM.Rahman,DPhil,** MomenM.Wahidi,MD,MBA, \u0192\u0192 AlainTremblay,MDCM,FRCPC,FCCP, \u2044\u2044 DavidW.Hsia,MD,\u00a7\u00a7 \u0001\u0001 FranciscoA.Almeida,MD,MS,\u00b6\u00b6SamiraShojaee,MD,MPH,FCCP,## LakshmiMudambi,MD,*** \u0192\u0192\u0192 AdamR.Belanger,MD, \u2044\u2044\u2044 HarmeetBedi,MD,\u00a7\u00a7\u00a7YaronB.Gesthalter,MD, \u0001\u0001\u0001 Margaret Gaynor,APN,CNP,\u00b6\u00b6\u00b6KarenL.MacKenney,APRN,### SandraZ.Lewis,PhD,**** andRobertoF.Casal,MD### Background: Whiletheef \u0001 cacyof Indwellingpleural cathetersforpalliationofmalignantpleuraleffusionsis supportedbyrelativelyrobustevidence,thereisless claritysurroundingthepostinsertionmanag ement.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Methods: TheTrustworthy Consensus-BasedStatement approachwasutilizedtodevelopunbiased,scienti \u0001 cally validguidan ceforthemanag ementof patientswith malignanteffusionstreatedwithindwellingpleural catheters.Acomprehensiveelect ronicdatabasesearch ofPubMedwasperformedbasedonaprioricrafted PICOquestions(Population/Intervention/Comparator/ Outcomesparadigm).Manualsearchesoftheliterature wereperformedtoidentifyadditionalrelevant ReceivedforpublicationApril1,2020;acceptedJuly14,2020.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Fromthe*DepartmentofPulmonaryMedicine,NavalMedicalCenterSanDiego; \u0192 DepartmentofMedicine,UniversityofCaliforniaSanDiego,San Diego; \u2044 DepartmentofMedicine,DivisionofPulmonaryandCriticalCare, LomaLinda UniversityMedicalCenter,LomaLinda; \u00a7\u00a7Harbor-UniversityofCaliforniaLosAngeles MedicalCenter; \u0001\u0001 LosAngeles BiomedicalResearchInstituteatHarbor-UniversityofCalifornia LosAngeles,Torrance;\u00a7\u00a7\u00a7DepartmentofMedicine,DivisionofPulmonaryandCriticalCareMedicine,Stanford UniversitySchoolofMedicine, Stanford; \u0001\u0001\u0001 DepartmentofPulmonary,CriticalCare,AllergyandSleepMedicine, UniversityofCaliforniaSanFrancisco,SanFrancisco,CA; \u00a7CentreforRespiratoryResearch,SchoolofMedicine;\u00b6Institute forRespiratoryHealth,UniversityofWesternAustralia; \u0001 Departmentof RespiratoryMedicine,Sir CharlesGairdnerHospital;#EdithCowanUniversity,Perth,WA,Australia;**OxfordRespiratoryTrials Unit, Nuf \u0001 eld DepartmentofExperimentalMedicine,UniversityofOxford,Oxford,UK; \u0192\u0192 DepartmentofInternalMedicine,DivisionofPulmonary, Allergy, andCriticalCareMedicine,Duke UniversityMedicalCenter,Durham; \u2044\u2044\u2044 Sectionof InterventionalPulmonology,Departmentof Medicine, UniversityofNorthCarolina,ChapelHill,NC; \u2044\u2044 Department ofMedicine,CummingSchoolofMedicine,UniversityofCalgary, Calgary,AB,Canada;\u00b6\u00b6RespiratoryInstitute,ClevelandClinicFoundation,Cleveland,OH;##Department of InternalMedicine,Divisionof PulmonaryandCriticalCareMedicine,Virginia CommonwealthUniversity,Richmond,VA;***SectionofPulmonary&CriticalCareMedicine, VAPortlandHealthCareSystem; \u0192\u0192\u0192 DepartmentofMedicine,DivisionofPulmonary&CriticalCareMedicine,OregonHealth&Science University,Portland,OR;\u00b6\u00b6\u00b6Chi cagoChestCenter,Chicago;****EBQCons ultingLLC,Northbrook,IL;and ###DepartmentofPulmonary Medicine,TheUniversity ofTexasMDAndersonCancerCenter,Houston,TX.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "RussellJ.Miller,MD,CDR,MC,USNisamilitaryservicememberorfederal/contractedemployeeoftheUnitedStatesgovernment.Thi sworkwas prepared aspartof hisof \u0001 cialduties.Title17 U.S.C.105providesthat \u201a copyrightprotectionunderthistitleis notavailableforanyworkofthe UnitedStatesGovernment.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "\u2122 Title17U.S.C.101de \u0001 nesUSGovernmentworkasworkpreparedbyamilitaryservicememberoremployeeofthe USGovernmentaspartofthatperson \u2122 sof \u0001 cialduties.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Theviews expressedin this articlere \u0003 ecttheresultsofresearchconductedbytheauthoranddonotnecessarily re \u0003 ecttheof \u0001 cialpolicy orpositionof theDepartmentoftheNavy,DepartmentofDefense,northeUnited StatesGovernment.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "TheseguidelineswereCommissioned andfundedbytheAmericanAssociationforBronchologyandInterventionalPulmonology.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "N.M.R.hasreceivedpersonalfeesforconsultancy workandanunrestrictededucationalgrantfromRocketMedicaland was theleadinvestigator of the MIST-2 trial,fundedbyunrestrictededucationalgrantfromRocheUK.Y.C.G.L.wasthe leadinvestigatorof AMPLE-1,AMPLE-2and currentlyAMPLE-3.RocketMedical providedfreedrainageequipmentforparticipantsinthesemulticenterrandomizedtrials.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Healsoservedon theadvisoryboardofCareFusion/BD(manufacturerofPleurxcatheter)andhasreceivedanunrestrictededucationalgrantfromRocketMedical UKforsupportofAMPLE-2.In addit ion,hewasacoinvestigator oftheMIST-2trial, fundedbyanunrestrictededucationalgrantfromRoche UK.A.T.wasaconsultant for,andreceipt ofroyaltiesforintellectualpropertyfromBDInc.(manufacturerofPleurXcatheter).Forthe remainingauthors,thereisnocon \u0003 ictofinterestorotherdisclosures.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Reprints:RussellJ.Miller,MD,CDR,MC,USN,DepartmentofPulmonaryMedicine,NavalMedicalCenterSanDiego,34800BobWilsonDrive, SanDiego,CA92134 (e-mail:russell.j.miller32.mil@mail.mil).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Supple mentalDigitalContentis available forthisarticl e.Direc tURLcitationsappearintheprintedtextandareprovidedintheHTMLandPDF versionsofthisarticleonthejournal \u2122 swebsite, www.bronchology.com.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "WrittenworkpreparedbyemployeesoftheFed eralGovernmentaspartoftheirof \u0001 cialdutiesis,undertheU.S.CopyrightAct,a \ufb01 workoftheUnited StatesGovernment \ufb02 forwhichcopyrightprotectionunderTitle17oftheUnitedStatesCode isnotavailable.Assuch,copyrightdoes notextendto thecontributionsofemployeesoftheFederalGovernment.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "DOI:10.1097/LBR.0000000000000707 O RIGINAL I NVESTIGATION J BroncholInterventPulmonol \u0001 Volume27,Number4,October2020www.bronchology.com | 229 Downloaded from http://journals.lww.com/bronchology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 07/18/2024 literature.Dualscreeningsatthetitl e,abstract,and full-textlevelswereperformed.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Identi \u0001 edstudieswere thenassessedforqualitybasedonacombinationof validatedtools.Appropriatenessfordatapoolingand formationofevidence-basedrecommendationswas assessedusingpredeterminedcriter ia.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Allpanelmem- bersparticipatedindevelopmentofthe \u0001 nalrecom- mendationsutilizing themodi \u0001 edDelphitechnique.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Results: A total of7 studies wereidenti \u0001 edfor formal qualityassessment,allofwhichweredeemedtohavea highriskofbias.Therewasinsuf \u0001 cientevidenceto allowfordatapoolingandformationofanyevidence- basedrecommendations.Panelcons ensusresultedin11 ungradedconsensus-basedrecommendations.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Conclusion: Thismanuscriptwasdevelopedtoprovide clinicianswithguidan ceonthemanag ementof patients withindwellingpleuralcathetersplacedforpalliationof malignantpleuraleffusions.Throughasystematic and rigorous process,managementsuggestionswere developedbasedonthebestavailable evidencewith augmentationbyexpertopinionwhennecessary.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "In addition, theseguidelineshighlightimportantgaps in knowledgewhich requirefurtherstudy.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "KeyWords: indwellingpleuralcatheter, pleuraleffusion, malignant,palliation,guidelines ( JBroncholInterventPulmonol 2020;27:229 \u0152 245) M alignantpleuraleffusion(MPE) isasub- st antialhe althcare burde n.Itsigni \u0001 es advanceddisease,usually resultsinsymptomatic patientmorbidity,andisassociatedwithapoor overallprognosis.Con sequently, MPEleadsto > 125,000hospitalizationsannuallyintheUnited Statesandcontributestoover$5billioninhealth carecosts.",
            "Tag": "Keyword"
        },
        {
            "Type": "Paragraph",
            "Text": "1 Therefore,ef \u0001 cientmanagementofthe conditionisofutmostimportancetooptimizing healthcareresour ceutilizationandenhancingthe quality ofa patient \u2122 sremaininglifespan.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Thereisnosinglebestapproachtode \u0001 nitively managerecurrentMPE.Twoofthemostwidely usedmethodsarechemicalpleurodesis,achievedvia eitherbedsideorthoracoscopicmeans,andinsertion ofan indwellingpleuralcatheter(IPC).Therelative advantagesanddisadvantagesof each,alongwith supportingliterature,are presentedanddiscussedin arecentexpertclinicalpracticeguidelinepublished onbehalfoftheAmericanThoracicSociety (ATS), theSocietyofThoracicSurgeons(STS),andSociety ofThoracicRadiology(STR).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2 Theseguidelines reinforce themultipleapproachesavailable,which varybasedonfactorsincludingunderlyingdisease characteristics,prognosis ,clinician expert ise, and patient-relatedconsideratio nssuchassocialsituation andpersonalpreference.",
            "Tag": "Reference"
        },
        {
            "Type": "Paragraph",
            "Text": "Nevertheless,duetotheef \u0001 cacy,practicality, andsafetypro \u0001 le,IPCshave emergedasapre- ferredtoolformanycliniciansaimingtoef \u0001 - ciently palliateMPEs.IPCplacementisrelatively straightforward,usuallyperformedinanout- patientsettingunderminimalornosedation,and decreases theneedforfuture palliative interve- ntions.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "3 Thisoffersanattractiveandminimally invasiveoptionforpatientsseekingtoenhance qualityof life(QoL) andlimittimespentinthe hospital.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Accordingly,insertionofIPCshas expandedconsiderablyinthelas tdecade.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "While theaforementionedATS/STS/STRdocument advisestheclinicianonthepotentialapproach toapatient withMPE,similarrecommen- dationsdonot exist formanaginganIPConce placed.Ourobjectivewastoevaluatetheexist- ingliteratureandproviderecommendationsfor vari ousaspectsofIPCu til izationpostinsertion includingdrainagefre quency,m anagementof catheterdysfunctionandassociatedi nfecti on, andfollow-upcare.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "METHODOLOGY Therearelimitationsindevelopingevidence- basedguidelineswithnewer medicaldevices dueto gapsint heevidencebase,smallsamplesizes,a paucityofmethodologicallyrigorousrandomized controlledtrials(RCTs),andvariationinusageand techniques, limitingthefea sibility of quantitative analyses.Underthese constraints,itisimportantto providephysicians,otherhealthcar eproviders,and patientswithtrustedadvice.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "4 \u0152 6 TheAmerican Asso ciatio nfor Bro nch osco pyan dInterven tio n al Pulmonology(AABIP)selectedtoemploy the Trustwor thyConsens us-BasedStatement(TCBS) approach, 7 alreadyutilizedbyseveralmedicalpro- fessional societies.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "8 TheTCBSapproachresultsin unbiased,scienti \u0001 callyvalid, standards-compliant, andtrustworthyguidancebasedonboththe avail- ableevidence,identi \u0001 edinasystematicapproachto reducebiases, and expertclinical advice.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "TheTCBSapproachbringsthoroughness andtransparencytotheconsensus ofexperts duringtheguidelinedevelopmentprocess.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "6 This approachisbasedon5important pillars: \u0001 Con \u0001 denceinthepanelcompositionand screening.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "\u0001 Systematic andcomprehensi veevidencesearches.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "\u0001 Formalmethods forconsensusachievement.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "\u0001 Transparencyofdataandmethodsthroughout.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "\u0001 Rigorousreviewofbothmethodsandcontent byinternalandexternalstakeholders.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "MilleretalJ BroncholInterventPulmonol \u0001 Volume27, Number4,October2020 230 | www.bronchology.com Downloaded from http://journals.lww.com/bronchology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 07/18/2024 Pa nelComposition andScreening Panel selection forphysicianswasbased on previouspublicationrecord inpleuraldiseasesand willingness toparticipate,whileadvanced-practice providerswereselectedbasedonreputationand willingnesst oparticipate.Aminimum procedural volumeand/ornumberof publicationsrelatedtothe managementofMPEsandIPCswasnotusedin determiningeligibilityforpanel inclusion.Thepanel wascomposedof14interventionalpulmonologists (including1chairmanand1co-chairman),and2 advanced-practiceproviders.Allpanel members participatedequally withoutdifferentiationssuchas \ufb01 expert \ufb02 or \ufb01 writingcommittee.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "\ufb02 Con \u0003 ictsofinterest weredisclosed and vetted bythePanel Chair(s).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "All panelistsreceivedtrainingontheTCBSprocess.The PanelChairsoversight includedadherencetometh- ods,assuranceoftransparency,andproject management.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "PICOQuestionDevelopment Thepanelchairandco-chairdeve lopedthe initialbroadcategoriesofIPCmanagement f orthe developmentofPICO(Population/Intervention/ Comparator/Outcomes paradigm)questions: Category1:RoutinemanagementofIPC patients,suchasQoL,drainageschedules, andpatientmonitoring.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Category 2:Mechanicalcomplicationsof IPCssuchascatheter obstruction.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Category3:InfectiouscomplicationsofIPCs including identi \u0001 cation,treatment,andprev- ention.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Asubgroupofpanelmemberswasassignedto eachcategoryandtaskedwithdevelopingadraft ofPICOquestions fortopicswithinthecategory.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "AfterdraftPICOquestions weredevelopedall panelmemberswereallowedtosuggestadditional PICOquestionsregardlessofcategoryassign- ment.Allmembersthenparticipatedinopendis- cussions(via emailandphoneconferences)to discussthemeritsof theindividualPICOques- tions andtosuggestmodi \u0001 cations.Thechair and co-chairthendecidedonthe \u0001 nalsetofPICO questionsbasedontheinputofpanelmembers.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "SystematicandComprehensiveLiteratureReview Theevidence-informedrecommendations (call- edsuggestionsfortransparency \u2122 ssake) weresup- portedbyacomprehensiveandsystematicsearchof PubMedforrelevantscienti \u0001 cliteratur e.Additional relevant literaturewasidenti \u0001 edthroughmanual searchesperformedbythepanelmembership.The searchstrategieswerede velopedbasedona priori craftedPICOque stionsandappliedfromJ anuary 2000toJanuary2019.Details ofsearchstrategies areincludedinthe online supplement(Appendix 1, SupplementalDigitalConte nt1,http://links.lww.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "com/LBR/A205).Studies wereincludediftheymet thefollowingcriteria:(1)publicationsinEnglish,(2) IPConlyutilizedforMPEorsuspectedMPE,(3) clinicaltrials,wellconductedretrospectivestudies, meta-analyses,or systematicreviews.Thefollowing studieswereexcluded:(1)expertreviews,(2)case reports,(3)ret rospectivestudiesorcaseserieswith < 50patients.Thesearchyi eldwasthenscreenedfor studieswithprimaryorsecondaryoutcomes addressingthePICOorsub-PICOquestion.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Dual screenings atthetitle anda bstractlevel,followedby dualscreeningofthefulltextswereperformed.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Third-partyadjudicationwasutilized when dis- agreementsoccurred.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Thestudieswereassessed for qualitybasedonacombinationofthevalidated tools,determinedinadvance foruse basedonstudy design.TheRoB2 9 assessment toolwasu sedto assessrandomizedstudies,theROBINS-I 10 was usedfor nonrandomizedinterventionstudies,and theSpecialistUnitforReviewEvidence(SURE) checklist 11 wasusedforevaluation ofcaseseries.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Thedecisiontoutilizedatapoolingtoforman evidence-basedrecommendationwas basedonthe criteriautilizedbythe CHEST guidelineoversight committee.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "7 Thisthresholdrequiresidentifyinga minimum of2studies(RCTorobservational)of atleastfairqualitywhichmeetinclusioncriteria andevaluate comparableoutcomesorinter- ventions.Whenthisthresholdisnotmet,acon- sensus-basedapproachguidedbylowerquality evidenceandexpertopinionis utilized.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "FormalMethodforConsensusAchievement The Delphitechnique isawidelyusedandwell- acceptedprocessforsolicitingfeedbackandach- ievingconsensus.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "12 Althoughthereareseveral variations, 13 \u0152 16 themodi \u0001 edDelphiapproachfor guidelinerecommendationsallowsconsiderationof theevidencebas easwellas expertopinion,while suppressingtheintroductionofgroupinteraction bias.Panelchairsdraftedtheinitialsuggestionsfor the \u0001 rstsurveyinformedbytheevidenceandexpert clinicaljudgment.Allinitialsuggestionswere draftedrecommendingthemost invasivepotential strategiesregardlessofthechair \u2122 sinterpretationo f evidence,personalclini calj udgment,or expected panelresponsestoavoidbiasingthemembership.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Allmembers,exceptforthechair,co-chairand methodologistelectronicallyvotedon agreement witheachdraftedsuggestionusinga5-pointLikert J BroncholInterventPulmonol \u0001 Volume27, Number4,October2020 AABIPEvidence-informed PleuralCatheterGuidelines www.bronchology.com | 231 Downloaded from http://journals.lww.com/bronchology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 07/18/2024 scalewithoptionsrangingbetween stronglyagree andstronglydisagree.Pane listswere notpermitted todiscussthedraftedrecommendationsotherthan intheopencomments \u0001 eldduringtheanonymous votingto avoid theoccurrenceorperception of groupinteractionbias.The chair andco-chair abstainedfromvotingastheyhadaccesstothe membership \u2122 scommentsbeforedeidenti \u0001 cation.Up to3roundsofanonymousonlines urveyswere performedwithinterimrevisionsbythePanel Chairsbasedon voters \u2122 feedback.Verbatimanon- ymouscomments,fromthe previousroundofvot- ing,were providedtothepanelmembersalong with theinterimrevisions.Apriorirules de \u0001 nedcon- sensusas \u0003 80%ofrespondentseitherstrongly agreeing oragreeing withth e recommendation,with aminimalresponserateof75%.Panelmembers whodisagreed withthe \u0001 nalconsensusrecom- mendationwere giventhe opportunitytoinclude a \ufb01 minorityreport \ufb02 accompanyingtherecom- mendationinthe \u0001 nalmanuscript.Finals ur vey talliesindicatingthevoti ngpercentagesareincluded intheonlinesupplement(Appendix2,E-Figs.2a \u0152 2k,SupplementalDigitalContent2,http://links.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "lww.com/LBR/A206).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "TransparencyandReviews IntheTCBSprocess,fulltransparency means recommendationsarecalledsuggestionsandare notgradedbutmarkedasconsensus-based.Final suggestions,onceconsensuswasachieved,canno longerbe changed.Remarksthataccompanythe suggestionsshouldbeconsideredpart of thesug- gestion.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "TheAABIPadvisesthat assuggestionsare uploadedintodigitalplatforms,incorporatedinto separatelists,orotherwiseremoved from thisfull guidelinepublication,the remarksshouldalwaysbe keptwiththerestofthesuggestionasasingleunit.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "ManuscriptsweredraftedandrevisedbythePanel Chairs.Initialreviewoftherevisedmanuscript wasperformed byacoregroupofthe 5most senior andexperiencedmembers,modi \u0001 cations weremadeuntil thegroupagreedwithcontent.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Thefullpanelthenreviewedthemanuscript and wasgiven an opportunitytocommentbefore \u0001 nal submission.Inadditiontomany iterations bythe chairs andpanelists,reviewsofthemanuscripts andprocesseswereconductedby leaders inthe AABIP.TheAABIPleadershipreviewwassolely forthepurposeofoversightandsocietal endorsement.TheAABIPdid notparticipatein guidelineormanuscriptdevelopment.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Patients andhealthcareprofessionals can trustthe methodsandrelyonthe \u0001 nalsuggestionstoguide clinicalpracticedecisions.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "DiversionsFromtheProcess NodiversionsfromtheTCBSprocessoccurred.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Futu re Updates Astheevidencebaseevolvesin thisrelatively newarea,theAABIPwill maintainthecurrency oftheserecommendationsemployingmethodo- logicallyrigoroustechniqueswith updatedliter- ature searchesandquantitativeanalyses.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Funding Thesolesourceoffundingfortheseguide- lineswas theAmericanAssociationforBron- choscopyandInterventionalPulmonology.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "RESULTS Followingdualscreeningat thet itle,abstract andfull-textlevels ,atotalof7studies 17 \u0152 23 were identi \u0001 edwhichmetcriteria forqualityassessment.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Theoverallsearchresultsarehighlightedasa PreferredRep orti ngItemsforSystematicReviews andMeta- Analyses(PRISMA)diagram(Fig.1) an din di vi d ualPRISMAd iagramsforeachPICO questionareincludedintheonlinesupplement (Appendix1,E-Figs.1a \u0152 1u,SupplementalDigital Content1,http://links .lww.com/LBR/A205).Two RCTs 21,22 wereevaluatedwiththeRoB2, 9 3 nonrandomizedinterventionstudies 18 \u0152 20 with ROBINS-I, 10 and2 case series 17,23 requiredthe Specialist Unit forReviewEvidence(SURE) checklist.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "11 Alltheassessments revealedhigh/seri- ousrisksofbias.Detailedresultsareavailable uponrequestandtheevidence table(E-Table1, SupplementalDigitalContent3,http://links.lww.",
            "Tag": "Table Data"
        },
        {
            "Type": "Paragraph",
            "Text": "com/LBR/A207)isincludedintheonlinesupple- ment.Additionalliterat uremonitoring tookplace inDecember2019con \u0001 rmingthattherewereno addi tion alstudiespublishedthatmet theinclusion criteria.Thethresholdt oformanevidence-based recommendation,basedont hecriteriautilized by the CHEST guidelineoversightcommittee 7 were notmetforanyofthePICO questions.Therefore, noformaldataextractionswereconducted,and all suggestionswerebasedontheTCBSapproach.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Recommendation 1: InpatientswithIPCsforthemanagementof known or suspectedMPEswithoutevidence of trappedlung,wesuggestdailydrainageofthe IPCwhen,in addition to symptomcontrol, achievingpleurodesisandcatheterremovalisan important patient-centeredgoal.Whenpleurod- esisandcatheterremoval isunlikelyornot MilleretalJ BroncholInterventPulmonol \u0001 Volume27, Number4,October2020 232 | www.bronchology.com Downloaded from http://journals.lww.com/bronchology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 07/18/2024 consideredimportant,lessfrequentdrainage schedulesorsymptom-baseddrainageisappro- priate (UngradedConsensus-BasedStatement).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Background De \u0001 ningandbalancingthegoalsof IPCther- apyforpatientswithMPEsisimportantwhen decidingonadrainage schedule.Theprimary intentofIPCsin thesepatientsiss ymptompallia- tionthatenhancesQoLandminimizesadditional interventionsandhe althcare visits.The literature consistently supportstheef \u0001 cacyofIPCsinach- ievingthesegoals.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "3,24,25 Therefore,drainingthe pleuralspaceasneededtoaccomplishthedesired effectmay beenough.However,achieving spontaneouspleurodesisthatallowscatheter removalisalsoanimportantoutcomewhichmay bein \u0003 uencedbydrainagefrequenc y.Thelike- lihoodofachievingspontaneouspleurodesis,t he expectedlifespanofthepatientandtheir personal preferencesallneedtobeconsideredwhendeciding onanidealdrainageschedule.",
            "Tag": "Reference"
        },
        {
            "Type": "Paragraph",
            "Text": "SummaryofEvidence (1)EffectofdrainagescheduleonQoL: When catheter removalis notconsideredanimportant outcomethereisverylittledatasupportingaggres- sivedrainageregimensimproveQoLordyspnea.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "The AMPLE-2t rialcompareddailytosymptom- guideddrai nageoverthe \u0001 rst60 days after catheter Records identified through database searching (n = 216) Additional records identified through other sources (n = 122) Records after duplicates removed (n = 308) Records screened (n = 92) Abstracts excluded (n=64) Does not address PICO question: n=26 < 50 patients in retrospective or case study: n=18 Review article: n=13 Animal study: n=2 Not available in English: n=1 Protocol notification only: n= 3 Pediatric study: n=1 Full-text articles assessed for eligibility (n = 28) Full text articles excluded (n=21) Does not address PICO question: n=15 Malignant subset < 50 patients and retrospective: n=1 Descriptive without comparison: n=5 Studies included in qualitative synthesis (n = 7) Randomized control studies: n=2 Non-randomized intervention studies: n=3 Case series: n=2 Studies included in quantitative synthesis (meta-analysis) (n = 0) Records excluded Non-relevant titles (n = 216) FIGURE1.",
            "Tag": "Figure Caption"
        },
        {
            "Type": "Paragraph",
            "Text": "PreferredReportingItemsforSystematicReviewsandMeta-Analyses(PRISMA)flow diagramof study selection.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "J BroncholInterventPulmonol \u0001 Volume27, Number4,October2020 AABIPEvidence-informed PleuralCatheterGuidelines www.bronchology.com | 233 Downloaded from http://journals.lww.com/bronchology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 07/18/2024 placement.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "22 Inthesymptom-basedgroup,drain- ageswereperformedatamedianfrequencyofevery 5.45days.Differenceinbre athlessnessbetweenthe groups was measuredusingthe VisualAnalogScale ( VAS)breathlessnessscore.Broaderdif ferencesin QoLweremeasuredwiththeVAS-QoLscoreand theEuroQoL-5Dimensions-5Levels (EQ-5D-5L) QoLassessment.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Whiletheprimaryoutcomeof VASbreathlessnessscorewassimilarbetween groups,therewasastatisti callyandclinicallysig- ni \u0001 cantimprovement inthe EQ-5D-5Lscore,as wellasanonsigni \u0001 canttrendtowardimprovement in VAS-QoLscoresintheaggressivedailydrainage group.Nobetween-groupdifferenceswerefoundin painscores,complications,inpatienthospitaldays, ormortality.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "TheASAPtrialwasdesignedtoevaluaterates ofautopleurodesisbetweendailydrainageand every-other-daydrainage , butincludedsecondary outcomesofQoLusingtheKarnofskyperform- ance scale andtheSF-36 score atbaseline,2 weeks postinsertion,and12w eekspostinsertion.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "21 It foundnodifferencesinthesemeasuresbetweenthe 2groups.Overallpatientsatisfactionscoresand frequencyofadverse eventswere alsosimilar.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "(2)Effectofdrainagescheduleonpleurodesis: Themajorityofcurrentlyavailabledataguiding optimaldrainageschedulesforpurposesofach- ievingpleurodesisa lsocomesfromtheASAPa nd AMPLE-2trials.IntheASAPtrial,theprimary outcomeofautopleurodesiswasachievedata higherrateinthedailydrainagegroupthanthe every-other-dayd rainagegroup(47% vs.24%)at the endof the12-weekstudyperiod.However, substantialsubjectlossestofollow-upaswellas earlydeathsinthelatterarm introduces uncer- taintyinthis conclusion.Althoughnottheprimary outcome,theAMPLE-2trialfoundthatadaily drainageschedulewassuperiortothes ymptom- basedprotocolatachievingpleurodesisat60days (37.3%vs.11.4%).Thisadvantagep ersistedat 6months (44.2%vs.15.9%).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Justi \u0001 cation forRecommendation Werecognizethatspontaneouspleurodesis andsubsequentcatheterremovalareimportant and realisticoutcomesinselectedpatients,such as thosewithexpandablelungandinwhom persistenceofthecatheterrepresentsapractical burden.Forthesepatients,thecommitteesug- gests adailydrainageschedulebasedonthe resultsof theASAPandAMPLE-2 trials.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Ifcatheterremovalisnotanimportantpatient- centeredoutcome,thecommitteecannot recommend aggressivedrainageschedules.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "While therewasasmallimprovementinsecondaryQoL scoresforp atientsin theaggressivedrainagearmof theAMPLE-2trial,therehasbeennoconvincing evidencetodatetosupportaggressive dr ainagefor thepurposeofimprovingbreathlessnessorQ oL.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Thecommitteeisalsounabletoendorsean aggressivedrainageprotocol in patientswith lim- itedlife-expectancy(eg, \u0004 3mo)asevenifpleu- rodesisisachievedbeforedeath,theremainingtime withou tthecatheterwillbeshort.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Recommendation 2 InpatientswithIPCsforthemanagementof knownor suspectedMPEswithsuspectedtrap- ped lung,wesuggestthattheidealdrainage scheduleisunknownandshouldbedecidedon anindividualcasebasis.Dailydrainageof the IPCmightbe consideredwhen,inadditionto symptomcontrol,achievingpleurodesisand catheterremovalisconsideredanimportantgoal, aspleurodesismightstillbepossible.Conversely, aggressivedrainagemayresultinincreasedchest discomfortinsomeindividuals, andifpresent shouldleadtoless frequentorsymptomatic drivendrainageschedules(UngradedConsensus- BasedStatement).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Background Inthepresenceofanonexpandablelung,pleu- rodesisproceduresareunl ikely tobesuccessful 26 andIPCsaregenerallyconsideredthestandardof careforsymptommanagement.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "27 Nonexpandable lungisoftennot reversiblewhenassociatedwitha \u0001 brousnoncompliantvisceralpleuracausedby chronicin \u0003 ammation.However,lat ereexpansion canoccasionally occur inthesettingofmoreactive pleuralprocesses.Availablebedsidemethods for assessingt hepleuraandpleuralelastance,suchas pleural manometryand ultrasound, havenotbeen showntopredictlatelungreexpansion.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "28,29 SummaryofEvidence Although,byde \u0001 nition,pleurodesisisnotpos- sible withatrulynonexpandablelung,patientspre- sumptively diagnosedwithnonexpandable lung mightstillbeabletoachievepleurodesis.Inapost hocanalysisofAMPLE-2 trial,whichcompared dailypleuraldrainagetosymptom-baseddrainage, therewasasmallsubgroupof28patientscategorized withtrappedlunginwhich4(14.3%)wereableto achievepleurodesisat60daysand8(28.6% ) wereabletoachievepleurodesisat6 months.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "22 Themaj orityo fsuccessful pleurodesisoccurredin patientsundergoingdailydrainage.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "At6months, MilleretalJ BroncholInterventPulmonol \u0001 Volume27, Number4,October2020 234 | www.bronchology.com Downloaded from http://journals.lww.com/bronchology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 07/18/2024 7of14patients(50%)inthedailydrainagegroup achievedpleurodesiscomparedwith1of14patients (7.1%) inthesymptom-drivengroup.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Justi \u0001 cation forRecommendation While,intheAMPLE-2trial,latelungr eex- pans ionwasmorecommonintheaggressive drainagegroup, thedataisbased onaposthoc analysisofonly28totalpatients.Inaddition,daily drainageisnotwithoutitsrisksinpatientswith nonexpandablelungasdrainagecan resultin sig- ni \u0001 cantpainwhichc anbequitedistressingtothe patient.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "30 These symptomsoftenlimitdrainage volume,whichlikely furtherreducesthechancesof obtainingpleurodesis.Whileitisnotunreasonable toattemptdailydr ainageinpatientswhodonot developpainorothersymptomsrelatedtodrain- age,thereislikelylittlebene \u0001 ttoaggressive drainageschedulesinthosewhododevelop symptoms withdrainage.Inthis subseteitherless frequentscheduleddrainageorsymptom-based drainage are likelymore appropriate.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Recommendation 3 InpatientswithIPCs forthemanagementof knownorsuspectedMPEs,wesuggestthat,evenin the absenceof catheter-relatedconcerns,regular clinicalfollow-upwit haproviderexperiencedin the managementof IPCsshouldbeoffered,with thefrequencydecidedonanindividualbasis (UngradedConsensus-BasedStatement).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Background Aswithanyongoingtherapythatinvolves indwellingmaterial,availabilityofexperienced providerstoanswerquestions regardingmain- tenanceandevaluate for potential complications isconsideredstandardof care.Intheabsenceof activecatheter-relatedconcerns,thereareseveral factors,suchasavailabilityofhomehealth nurses, reliabilityofcaregiversandpatientpref- erences,thatshouldbeconsideredwhendeciding onneedandfrequencyoffollow-up.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "SummaryofEvidence Thevalueofroutine clinicalfollow-upin patientswithIPCsforthemanagement ofpleural effusions hasnotbeenexploredintheliterature, andthereforethecommitteemakesthisrecom- mendationbasedsolelyonexpertopinion.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Justi \u0001 cation forRecommendation Itseemsreasonablethat regularfollow-up carecouldproactivelyidentify problemsorcon- cerns whichthepatientand/orcaregivermight nototherwiserecognize.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "However, thepotential bene \u0001 tofsuchregularvisitsshould bebalanced againsttheirpotentialpracticaland \u0001 nancial burdenofexcessiveof \u0001 cevisits.Morefrequent visits arelikelybene \u0001 cialinpatientswithless reliablecaregiversandthosewhofail todemon- strate astrongunderstandingofpotentialcom- plicationsandtroubleshootingtechniquesdespite attemptsattraining.Incontrast, regularclinical follow-upcanlikelybelimitedto an as-needed schedulewhencathetersaremanagedbyahos- piceteam,experiencedhomehealthnurses,orby areliableand medicallycompetentfamilycare- giver.Atminimum,thecommitteerecommends someformofclinicalfollow-upbe offeredtothe patient,eitherbyphone orinperson,andshared decision-makingused toguidesubsequentvisits.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Theeffectofregularclinicalfollow-uponQoL andcomplicationsremainsunknownandfuture researchisnecessaryto help clarifythisimpor- tantquestion.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Recommendation 4 InpatientswithIPCsforthemanagementof knownorsuspectedMPEsandsymptomaticpleural \u0003 uidreaccumulationduetoanondrainingpleural catheter,wesuggestsaline \u0003 ushingofthecatheterto relieveanyobstruction.Ifsalineisunsuccessfulat relieving theobs truction,andtherearenocontra- indications,instillationof \u0001 brinolyticsviathecath- etershouldbeattemptedtorestore \u0003 ow(Ungraded Consensus-BasedS tatement).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Background Reduceddrainagefr omanI PCcanindicate successfulpleur odesisor a poorlydrainingpleural space.Worseningdyspnea andincreasingeffusion onchestimagingsugges ts thelatterscenario.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "NondrainingIPCsinthesettingofsymptomatic pleural \u0003 uid reaccumulationhavebeenreportedto occurin5%to14%ofpatients.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "3,24,31 \u0152 34 As udden cessation ofpreviouslylarge-volumedrainagesug- gestsmalfunction ofthecatheter,whichismost commonlycaused by \u0001 brinocclusion.Catheter fractureandmigrationoutofthepleuralspace havealsobeenreported.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "32,35 However,when reductionindrainage is moregradualinthe setting ofapersistentorenlarging effusion,itis likely relatedtoincreasedpleural \u0003 uidviscosity,poor communicationofthe \u0003 uidwiththecatheterdueto loculations ,orpartialobs tr uctionof thecatheter.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "31 Inthecurrentlyavailableliterature,studiesdonot alwaysdifferentiatebetweenthesepotentialcauses.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Terminologysuchas \ufb01 catheterobstruction \ufb02 and \ufb01 symptomatic loculations \ufb02 aresometimesused int erchangeablytodescribecessationorreduction J BroncholInterventPulmonol \u0001 Volume27, Number4,October2020 AABIPEvidence-informed PleuralCatheterGuidelines www.bronchology.com | 235 Downloaded from http://journals.lww.com/bronchology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 07/18/2024 ofdrainageinthesettingofa persistentand symptomaticeffusion.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "SummaryofEvidence Wilshireetal 36 retrospectivelyreviewedthe chartsof172patientswithIPCs overa5-year periodinasinglecenter.Thirty-sevenIPCswere identi \u0001 ed asnondraining ofwhich29wereplaced for malignantorparamalignanteffusions.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Restorationof drainageoccurredinallIPCs followinginstillationofintrapleuralalteplase.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Aftersuccessfuldrainage,the18patients whodid notdieorundergo successfulpleurodesiseven- tuallyrequiredrepeatalteplase,all ofwhich were deemedsuccessful.Nocomplicationswere observedinthe study.Amajorlimitationwasthe useofaconservativedrainagevolumeof10 mL tode \u0001 netherapy success.Thisisnottypically consideredaclinicallymeaningfulvolumeand 22%ofthosedeemedsuccessful produced < 150mLof \u0003 uidposttreatment.The10 mL thresholdwasbasedonthe internalcapacityof thecatheterandtheassumptionthatin the presenceofresidual \u0003 uidanondrainingcatheter wasonlyduetoanobstructionwithinthecath- eter,ratherthan apoorlydrainingpleuralspace, forexampledue toloculations.Asmallincrease of \u0003 uidoutputwouldnotindicateadequate treatmentofanorganizedpleuralspace.While theclinicalrelevance ofthisstudyislimited,it doesdemonstratethesafetyofintrapleuralalte- plaseatdosesof 2to5mg.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Thomasetal 33 evaluatedtheuseo f \u0001 brino- lyticsforthe purpose ofrestoring \u0003 owtoa nondrainingcatheterin amulti-institutional retrospectivereview.Thisstudyused theterm \ufb01 symptomatic loculations \ufb02 todescribeanon- drainingcatheterinthesettingofradiographic evidenceofresidualpleural \u0003 uid,witheffusion- relatedbreathlessnessandabsenceofevidenceof pleuralinfection.Intotal,66patientswereana- lyzed.After pleuralinstillationof \u0001 brinolytics, drainagevolumeincreasedin93%of patients,toa medianof500 mLat24hoursand900mLat 72hours.Inaddition,83%ofpatientshadan im provem entofbreathlessnessandtherewasa 21%decreaseofthesizeofeffusiononchestradi- ography at 2 hours.However,41%ofcatheters developedrecurrentobstructionatamedianof 13dayspostintervention.Tenofthesepatients receivedasecond \u0001 brinolytictreatmentwhilethe remaininghadthe catheterreplaced.Ofthose who wereretreated,only1hadsustainedeffect,possibly suggestingthedif \u0001 cultyinmanagingaple ural spaceproneto organization.Theonlyobserved complicationwass igni \u0001 cantnonfatalpleural bleeding whichoccurredin2 of66patients.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Asthestudywasamulticenterretrospective review,theprotocolsusedbetweeninstitutions variedresultinginaheterogenous dataset.The choice ofboth \u0001 brinolyticagentanddosevaried amongthe4centers.Whilemostpatients(79%) receivedalteplase,bothstreptokinase anduroki- nasewereusedaswell.Ofthosewhoreceived alteplase,individualdosesranged from4 to10 mgand upto 6dosesweregivento individual patientspertreatment.Dose-dependentand agent-dependentvariationsinoutcomesand complicationswerenotreported.Inaddition,as someinstitutionsdidnotcollectthe necessary datatoreport all outcomes,some ofthe \u0001 ndings werebasedonaverylimiteddataset.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Finally,in 2016thelargestandmostclinically relevantstudytodateoftheeffectof \u0001 brinolytics on anondrainingIPCwasperformedbyVialet al.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "17 Theadvantageofthisstudyisthatit incorporateda standardized,multistepalgorithmicp athwayin managingapoorlydrainingpleuralspace.Inthis retrospectivereview,patientswithabruptcessation of \u0003 uiddrainageorwithreductionindrainageto < 150mLon3consecutiveoccasionsonan every-other-dayschedulewouldreceiveachest radiograph.Iftheeffusionoccupied > 20%ofthe hemithorax,thecatheterwouldbe \u0003 ushedwith20mL ofsaline.Ifdrainagepostsaline \u0003 ushingremained under150mL,then4mgof alteplasewasinstilled intotheIPCfollowedbyaseconddoseifinitialdose wasunsuccessful.Ifdrainageremainedpoor,theIPC wasremovedandotherpalliativeoptions,toinclude catheterreplacement,wereconsidered.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Asthiswasaretrospectivereview,andonly patientswhoreceivedalteplasewerecaptured,the successofsaline \u0003 u shi ngal on et ore sto re \u0003 owwas notreported.Asingledoseofalteplasewasable to restore \u0003 owto > 150mLin85%(83/97)of patients.However,asintheaforementioned studies,reocclusionwascommon,occurringin 32%(27/83).A secondtreatmentafter reocclusion wassuccessfulin72%ofpatients,andunlike the Thomasstudy,themajority (87.5%)of patients hada sustainedresponseanddidnotrequire a third treatment.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Ofthe45patientswho had a baselineBorg scoreofatleast1andsuccessful drainage, symptomaticbene \u0001 twasonlyseenin 53%ofpatients.Asinthepreviouslydiscussed studies,complicationswereinfrequent, occurring in4%ofinstillations(5/121) with2casesofnon- fatalhemothorax,and3 infectiouscomplications.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "MilleretalJ BroncholInterventPulmonol \u0001 Volume27, Number4,October2020 236 | www.bronchology.com Downloaded from http://journals.lww.com/bronchology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 07/18/2024 Justi \u0001 cation forRecommendation Whilenoneofthestudiesspeci \u0001 callyeval- uatedtheef \u0001 cacyofsaline \u0003 ushestorestore IPC patency,the committeefeelsthis isanimportant \u0001 rststepbeforeattempting \u0001 brinolytictherapy.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Theef \u0001 cacy ofsaline \u0003 ushing tomaintain patencyofsmallborechesttubes hasbeen demonstratedto beeffectiveandsafe.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "37 In addition,whilenotdirectly evaluatedinthe lit- erature, clinicalexperiencesuggestssaline \u0003 ush- ingmaybe successfulatrestoring \u0003 owto many nondrainingIPCs.Italsoprovidesaneasy, cost- effectiveinitialassessmentinpotentiallydiffer- entiatinganoccludedcatheterfroman organized pleuralspacethatmayrequiremoreintensive treatment.Furtherstudy oftheef \u0001 cacyofsaline \u0003 ushingcomparedwith \u0001 brinolyticsiswarranted.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Alteplase,atadoserangebetween2and 10mg,isthe mostfrequentlyused \u0001 brinolytic agentinthepreviouslymentionedtrials.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "17,33,36 However, \u0001 brinolyticchoiceanddosingvaried anddata toguidespeci \u0001 cprotocolsarelimited.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Therefore,the committee doesnotrecommenda speci \u0001 c \u0001 brinolytic agentordosagewhen attempting torestorepatencytoanondraining catheter,andfuturestudyisnecessary.Contra- indications to \u0001 brinolyticsarealsounclear.The mostcommonlyencounteredcomplicationto intrapleural \u0001 brinolytics is pleuralbleeding.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "38 Whileacoagulopathylikelyincreasesthebleed- ingrisk, thedegreeofcoagulopathyassociated withan unacceptablebleedingriskisunknown.",
            "Tag": "Table Data"
        },
        {
            "Type": "Paragraph",
            "Text": "Therefore,atthis pointwesuggestclinicaljudg- mentbeusedwhenconsidering \u0001 brinolyticther- apyinpatients withelevatedbleedingrisk.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Recommendation 5 InpatientswithIPCsforthemanagement of knownorsuspected MPEsandsuspected catheter- relatedpleuralspaceinfections,wesuggest ob tainingpleural \u0003 uidformicrobiologicalstudies toguideantibiotictherapy.Theoptimalmethod of obtainingpleural \u0003 uid(eg,eitherbythor- acentesisordirectlyfromtheIPC)isunclearand warrantsfurtherstudy(UngradedConsensus- BasedStatement).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Background Inpatientswithtunneledpleural catheters, whodevelopsymptomsofpleuralspace infec- tions,culturescanbeusefulinguidingantibiotic treatment.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Asthereareseveralpotentialpatho- gens,initialtreatmentoftenrequiresbroadcov- erageandidenti \u0001 cationofaparticularorganism willallowfor expeditioustailoringoftherapy.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Thisisespeciallyimportantinpatients with limited life-expectancyrelatedtomalignancy,as morerapidnarrowingofantibioticsmayhasten timetodischargeandreducetheriskofcompli- cations,suchasgastrointestinal Clostridiumdif- \u0001 cile infections.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "39 SummaryofEvidence Themethodofobtainingcultures intheset- tingofIPC-relatedinfectionshasnotbeeneval- uatedintheliterature.Therecommendationsare thereforebasedonacombinationof indirect evidenceandexpertopinion.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Justi \u0001 cation forRecommendation Whilewef eelt hereisbene \u0001 ttoobtaining culturesfortheaforementionedreasons,themost appropriatemethodofobtainingpleural \u0003 uidfor cultureisunknown.TherateofIPCbacterialcol- onization hasnotbeen studied.However, extrap- olating fromindirectdata onecanassumethat colonizationdoesoccur,as withotherlong-term drainagedevices suchasurinary catheters.Ina 2010studyofnontunnele dpleuraldrains placed afterlung resection,83%o fpatientsd eveloped bacterialcolonizationwithin theirchesttubes within4days ofplacement.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "40 Consequently,pos- itivec ulturesobtainedfrom acatheterinthe absenceofclinicalfeaturestosupportinfection shouldbeinterpretedwithcaution.Duetothe risk ofobtainingfalse-positiveand/ornonrepresentative organismswhenpleural \u0003 uidiscollecteddirectly fromtheI PC,somecliniciansfavorthor acentesis todirectlyobtain \u0003 uid forcultures.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Othersbelieve cultures obtainedfrom the IPCare suf \u0001 cientina clinicalcontextsuggestiveofpleuralinfection,as studiesofother commonindwellingcatheterssug- gestbacteriawhichproducebi o \u0001 lmsareoftenthe precipitatingorganismininfections.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "41,42 Without furtherstudywecannotconc ludewhichmethod of obtaining \u0003 uidforculturesissuperioratthistime.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Recommendation 6 InpatientswithIPCsforknownorsuspected MPEsandcatheter-associatedcellulitisorexit- siteinfections,wesuggest atrial oforalanti- bioticswithcoveragefortypicalskinpathogensis appropriate,andcatheterremoval isonlyneces- saryinthesettingofantibioticfailure(Ungraded Consensus-Based Statement).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Background Currently,therearenouniversallyaccepted de \u0001 nitionscharacterizingsoft tissueinfection associatedwithIPCsandmanyofthede \u0001 nitions J BroncholInterventPulmonol \u0001 Volume27, Number4,October2020 AABIPEvidence-informed PleuralCatheterGuidelines www.bronchology.com | 237 Downloaded from http://journals.lww.com/bronchology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 07/18/2024 usedin theliteratureareextrapolatedfrom the peritonealdialysisliterature.Cellulitisisusually characterizedbyredness,warmth,edema, and mildpainoftheskinandimmediatesubcuta- neoustissue.However,clinicaljudgmentis neededtodifferentiateIPC-relatedcellulitisfrom noninfectiousskin \u0001 ndings.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Thesemayinclude localizederythemaassociated withthecatheter (especiallyintheimmediateperiodfollowing placement)oralocalizedreactionrelatedtofre- quentdressingchanges.Exit-siteinfectionscan bede \u0001 nedaspurulentdrainage atthecatheter- epidermalinterface,whichcanbeassociatedwith indurationanderythemaofthecathetertract, localizedwithin2moftheexitsite.Incontrast, tunneltractinfections canbede \u0001 ned aspresence of erythema,edema,indurationandtenderness alongthecathetertract, > 2cmproximalfrom theexitsite.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "42 \u0152 44 Some alsoadvocateforusing ultrasoundimagingtodemonstratea \u0003 uidcol- lectionalongthecathetertractsurroundingthe cuffasadditionalcriteriasupportingthe diagnosis.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "43 While tunnel tractinfectionsare oftenassociatedwithexit-siteinfectionstheymay alsooccuralone.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "SummaryofEvidence Theappropria temanagementofIPC-related softtissueinfectionshasnotbeen studied.The recommendationsarethereforebasedona combinationofindir ect evidenceandexpert opinion.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Justi \u0001 cation forRecommendation While weacknowledgethatresearchanalyzing peritoneal dialysiscatheters(PDCs)doesnotdirectly translatetoIPCs,thecommitteebelievesthe extracavitary componentsof IPCsandPDCsare similarenough that, when addressingthediagnosis and managementofcatheter-relatedskinsofttissue infections,extrapolationisr easonable.While the microbiologyo fcutaneousinfectionsassociated with IPCshasnotbeenwellcharacterized,withinthe PDCliteraturethemostcommonorganismsasso- ciatedwiththeseinfectionsareskincolonizers,such as Corynebacterium speciesandcoagulase-negative Staphylococcus ,aswellasmorevirulentorganisms suchas Pseudomonas aeruginosa and Staphylococcus aureus.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "45 InPDCpatients,oralantibioticswhich cover S.aureus speciesaret ypicallysuf \u0001 cienttot reat thesei nfections,whi lepatients withahistoryof pseudomonasinfectionsor methicillin-resistant S.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "aureus mightrequireantibioticswithmorebroad coverage.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "45 Whileantibioticsalonearetypically suf \u0001 cient,progressionofdiseasedoesoccasionally warrantcat heterremoval.Inarecentreviewof448 IPCsplacedforthemanagementofMPEsata singlecenter, 14patientswerediagnosed with localizedski ninfectionso fwhichonly2required catheterremoval.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "46 Recommendation 7 InpatientswithIPCsforthemanagementof knownorsuspectedMPEswhodevelopacatheter- relatedpleuralspaceinfectionwithoutaconcomitant tunneltractinfection,we suggestattemptingcon- tinuous \u0003 uiddrainagethroughtheIPCovercatheter removal(UngradedConsensus-BasedStatement).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Background Pleuralspaceinfectionsaregenerally reportedtooccurwith < 5%ofIPCs.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "23,32,44,47,48 Whilevariousde \u0001 nitionshavebeen used, we suggestanIPC-relatedpleuralspaceinfection exists whenanyofthefollowingarepresent:(1) obviouspus drainedfromthecatheter;(2)pres- enceofclinicalsymptomsconsistentwithinfec- tionwithpositivepleural \u0003 uidgramstainor cultures;(3)presenceofclinical symptomscon- sistentwithinfectionalongwithpleural \u0003 uid biochemicalanalysissupportiveofinfection,such aselevatedlactate dehydrogenase,lowglucoseor lowpH.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "44,49 Asalreadydiscussed,cathetercol- onizationisnotinfrequentandpositivecultures aloneshouldnotde \u0001 neapleuralspaceinfection.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "SummaryofEvidence In 2013,Fyshetal 23 retrospectivelyanalyzed 1021patientswith I PCstreated at11international centersofwhich50patientswithIPC-related pleuralinfectionswereidenti \u0001 ed.Inthistrialall patients wereinitially tre at edwithantibiot icsand catheterdrainage.OftheIPC-infectedpatients, 74%weretreatedasinpatients,3/50diedbefore infectionresolution,wi tha94%overallrateo f infection control.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Catheterremovalwasp erformed i n46%ofp atien ts.Inth osewhorequ i redIPC removal ,reinsertiono fachesttubeorIPCwas requiredin48%ofpatientsandnosurgicalinter- ventionswerenecessary f orinfectioncontrol.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "TheFyshstudy,wasthelargestcohortof IPC-relatedpleuralspaceinfections,withthe next3largest cohortsofMPErelatedIPCpleural spaceinfectionsincluded25,19,and13IPCs respectively.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "23 Bibbyetal 50 retrospectivelyana- lyzed672patientswithIPCforMPEsofwhich 25IPC-relatedpleuralinfectionswereidenti \u0001 ed.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "OftheIPC-infectedpatients,60%weretreatedas inpatients,3/25diedwithin30daysofinfection MilleretalJ BroncholInterventPulmonol \u0001 Volume27, Number4,October2020 238 | www.bronchology.com Downloaded from http://journals.lww.com/bronchology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 07/18/2024 diagnosis,andthe overallinfectioncontrolrate was 88%.Catheterremovalwas performedin 12%ofpatients.InthosewhorequiredIPC removal,nonerequiredreinsertion ofachesttube orIPCorsurgicalinterventions forinfection control.Porceletal 49 retrospectivelyanalyzed 279IPCsplaced forMPEsofwhich19IPC- relatedpleuralinfectionswereidenti \u0001 ed.Ofthe IPC-infectedpatients,23%weretreatedasinpa- tients;deathwasnotreportedspeci \u0001 callyamong thisgroup.Catheter removalwasnotrequiredin anyofpatientsandnosurgicalinterventionswere requiredforinfectioncontrol.Gilbertetal 51 used aprospective databaseof225patientswithIPC forMPEsofwhich13IPC-related pleuralinfec- tions wereidenti \u0001 ed.OftheIPC-infected patients,therewerenodeathsattributedto infectiouscomplicationswith a100%overallrate of infectioncontrol.Catheterremovalwas requiredin 69%ofpatients.Inthosewho requiredIPC removal,reinsertionofachesttube orIPCwasrequiredin33%ofpatientsandsur- gicalinterventionwasrequiredin22%ofpatients forinfectioncontrol.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Justi \u0001 cation forRecommendation Incomplicatedpleuralspaceinfections,the primary principlesofmanagementincludeanti- microbialtreatmentandsourcecontrolwithcom- pletedrainage,regardlessofthesourceandcause.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "52 Despitevariableratesofcatheterremoval,deaths fromIPC-relatedpleuralspaceinfectionsisrare.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "The lowestrateofcatheterremovalinthe recently publishedPorcelstudyislikelyaresultofknowl- edgegainedfromtheotherreviews.Giventhe extremelylowrateofIPCinfection-relateddeaths, immediateremoval ofan IPCisnotrecommended.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Inaddition,chesttubeplacementorIPCreinser- tionafterIPCremovali snotrequiredi nthe absenceofpleural \u0003 uid accumulation, asinfection- relatedpleuralin \u0003 ammationcausingpleurodesisis freque ntlyencountered.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Whiletheliteraturedoesnotspeci \u0001 cally addresstheroleofcontinuous drainageover intermittentdrainageforIPC-related pleural spaceinfections,guidelinesformanagingcom- plicatedparapneumoniceffusionsrecommend continuousdrainage viachesttube overserial drainagewiththoracentesis,albeitbasedon limiteddata.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "53 TheeaseofnoncontinuousIPC drainage mightleadsometoponderuseofa frequentintermittentdrainagestrategy,however, thishas notbeenstudiedandthecommittee suggestfollowingthe principleofcontinuous drainage applied toparapneumoniceffusions.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Whilemanypatientswillrequirehospital admission,continuousdrainagecanbeperformed intheoutpatientsetting using portablecontinuous chestt ubedrainagesystems,digitalsuctiondrain- agesystems, oreven asimplelegbag.",
            "Tag": "Table Data"
        },
        {
            "Type": "Paragraph",
            "Text": "54 \u0152 56 The decisionregardinginpatientoroutpatientman- ageme ntshouldbemadeonacase -by-c asebasis.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Recommendation 8 InpatientswithIPCs forthemanagementof knownorsuspectedMPEswhodevelopac athe ter- relatedpleuralspace infectionwhichcannotbe adequatelydraineddespi tecontinuousdrainage, wesuggestinstillationof \u0001 brinolyticsa ndDNase viathecathetertoaidincatheterdrainageand clearanceofinfection(UngradedConsensus-Based Statement).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Background Inadequatedrainageofaninfectedand organizedpleuralspacecanleadtopoorinfec- tioncontrol,furtherreducedpleuralcompliance, andworseningsymptomsand outcome.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "57 While surgeryisoftenaneffectivemeansofsterilizing thepleural space,patientswithMPEbeing treatedwithIPCsareoftenpoor surgicalcandi- dateswithlimitedlifespans.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "58 Therefore, non- surgicalinterventionsthatreducemorbidityand lengthof hospitalization,shouldbegivenpref- erentialconsiderationinthemanagementofIPC- relatedpleuralspaceinfections.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "SummaryofEvidence Currentlythereisapaucityofdata regarding theef \u0001 cacyofcombined \u0001 brinolyticsandDNase inthemanagementofIPC-relatedpleuralspace infections.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "InaretrospectivereportonIPC- relatedpleuralspaceinfections,Fyshetal 23 reviewed50patients, 13ofwhomreceivedsome formof \u0001 brinolytictherapy.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Of these patients, 85%achievedcompleteresolutionoftheinfec- tion withouttheneedforsurgicalintervention.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "However, only6ofthesepatientsreceivedcom- binationalteplaseandDNase.Inaddition,the rationaleforsingle agentversuscombination therapywas notprovided.There werenocom- plicationsreportedwiththisregimen.Theef \u0001 - cacyofintrapleuralalteplase combinedwith DNasein themanagementofparapneumonic pleuralspaceinfectionstoreduceneedforsur- gicalinterventionand durationof hospitalstay wasdemonstratedintheMISTIItrial.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "59 The applicabilityoftheMIST IIdatainthe J BroncholInterventPulmonol \u0001 Volume27, Number4,October2020 AABIPEvidence-informed PleuralCatheterGuidelines www.bronchology.com | 239 Downloaded from http://journals.lww.com/bronchology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 07/18/2024 managementofIPC-related pleuralspaceinfec- tionsthusfarisunknown.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Justi \u0001 cation forRecommendation Asthedirectdatawas limitedtoagroupof only6patentswithinaretrospectivereview,to guide the suggestionwe reliedsolelyonthe indirect dataextrapolatedfromtheMISTIItrial 59 and clinicalexperience.Weacknowledgethatthedif- ferencesinbiologybetweeninfectedMPEsand primary p leuralspaceinfectionsmightresultin differencesinbothef \u0001 cacyandbleedingrisk.The committee,however,believesthatbasedonclinical experiencecombinedintrapleuraltherapyfor treatingIPC-relatedpleuralspaceinfections,in patientswh odonothavecontradictions,i srea- sonable.Therearenohigh-qualitydata supporting singleagent \u0001 brinolyticsorDNaseintreating pleuralspaceinfections .Furthermore,theuseof DNaseasmonotherapyintheMIST IItrial resultedin worseningsystemicin \u0003 ammatory responseandmorefrequentsurgicalreferral.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "59 As such, thecommitteesuggestsavoidingDNase monotherapy inpleuralspaceinfectionsbutcannot recommendfororagainst \u0001 brinolyticmonotherapy inthissetting.Alargerseriesexaminingtheuseof alteplaseandDNaseinthemanagementofIPC- related pleural spaceinf ectionsisunderwaywhich maycontributetoanswe ringthisquestion.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "60 Recommendation 9 InpatientswithIPCs forthemanagementof known orsuspected MPEswho develop acatheter- relatedpleuralspaceinfection,wesuggestcatheter removalanddrainageofthepleuralspacewitha newc he sttubeshouldbec onsideredifanyofthe followingarepresent:atunneltractinfection,poor catheterdrainage despitetheuseof \u0001 brinolytics andDNase,orpersistentse psisdespiteantibiotic s andd rainagethroughtheo riginalIPC(Ungraded Consensus-BasedStatement).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Background Whileitappearsthatmany patient swith IPC-re la tedpleuralspac einfe ctionsc anbe treatedsuccessfullywithoutremovingthecath- eter,patientsmayrequireremovalinsituations wheninfectioncontrolis dif \u0001 cultorfailing.As such, identi \u0001 cationof indicationsforcatheter removaland replacementisanimportantpartof themanagementofpatientswithIPCsfor malignantdisease.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "SummaryofEvidence TheindicationsforIPCremovalinthesetting of pleuralspaceinfectionshasnot beenadequately evaluated in theliterature.Therecommendations arethereforebasedonacombinationofepi- demiologicaldatadiscussedinrecommendation7, indirectevidence,andexpertopinion.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Justi \u0001 cation forRecommendation Typically,treatmentoftunneltractinfectionsis similart ot hatofexit-siteinfectionsbutusually requirelongerantibioticcourses.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "42 However,a simultaneoustunnelandvisceralspac einfection maypredictapooreroutcome.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "In t hisscenario, the PDCliteraturepredict salowlikelihoodoferad- icationofinfectionwithoutcatheterremoval.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "61 \u0152 63 Oneexceptionisthepresenceofcoagulase-negative staphyloc occ alinfe ction,forwhic hhighrate sof cathet ersalvagehavebeenreported.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "62 While the indirectevidencefavorsremovalinthepresenceof virulentorganisms,thereisnodirectevidenceto supportthisstrategyin I PCpatients.Giventhelack ofdirectevidence andthe overal ll owmortality associatedwithIPC-relatedpleural spaceinfections, one mightconsideratrialofantibiotics withoutIPC removal, withtheundersta nd i ngth ati nthesetti ng ofvirulentorganisms failure rates are likelyhigh.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Whilethereisnoevidencetoguidedecisions regardingcatheterremoval,the committee believesthatfailuretorespondtotreatment, suggestedbyeitherpoorclinicalresponseor inadequateIPCdrainage, shouldpromptcathe- terremoval.Placementofanewchesttubefor continueddrainageisalsosuggestedinthesetting ofpersistent \u0003 uidafterIPCremoval.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Recommendation 10 InpatientswithIPCsforthemanagementof known orsuspectedMPEswhodevelop acath- eter-relatedpleuralspaceinfection,wesuggest empiricantibioticswithbroadcoveragefor catheter-relatedorganismsincluding S.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "aureus andgram-negativeorganisms,whileawaiting resultsofmicrobiologicaltesting(Ungraded Consensus-Based Statement).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Background WhilemostpatientswithIPC-relatedpleural spaceinfectionseventuallygrowacausative organismfromculture,promptempiricanti- microbialcoverageisacriticalpartofmanage- ment.Thechoiceofempiricantimicrobialagents dependsonthelocal epidemiologyofthepoten- tialculpritorganisms,whichinturndependson source.Itisimportant torecognizethatcultures MilleretalJ BroncholInterventPulmonol \u0001 Volume27, Number4,October2020 240 | www.bronchology.com Downloaded from http://journals.lww.com/bronchology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 07/18/2024 mayultimately beunrevealingoronlygrow contaminantorganisms.In theabsenceoffrank pus, it isproblematicto relysolelyonpleural spacebiomarkersassociatedwithinfection(low glucose,low pH,highlactatedehydrogenase) sincethis pro \u0001 lecan alsobeseeninnoninfected MPEs.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "64 Our recommendationandthe following discussionassume ahighsuspicionforIPC- relatedpleuralspaceinfection.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "SummaryofEvidence Theevidenceanalyzingthemicrobiologyof IPC pleuralspaceinfectionsislimitedandbased onsmallretrospectivereviews.Pleural \u0003 uidcul- turestypicallyidentifyanorganism in IPC- relatedpleuralspaceinfections.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "50,65 InFysh etal \u2122 s 23 retrospectivereviewof50IPC-related pleuralspaceinfections,pleural \u0003 uidsampling identi \u0001 edanorganismin48patients.Intotal,17 different organismswereidenti \u0001 edofwhich6 patients hadmultipleorganisms.Thepredom- inantorganismwas S.aureus whichwasisolated in48%of cases,followedbygram-negativebac- teriaat18%.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "P.aeruginosa was themostcommon ofthislattergroup(10%ofallcases).Gram- positiveorganismsotherthan S.aureus were found in14%ofpatients,whileanaerobic organismswereisolatedinonly6%.Themedian antibioticdurationwas 24days;however,the authorsdidnotreportanyspeci \u0001 ccriteriafor selectingdurationoftherapy.Inaddition,38%of patientsreceivedonlyoralantibioticsandthe authorsdidnotidentifydifferencesinresponse ratecomparedwithintravenousagents.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Justi \u0001 cation forRecommendation Sincetheef \u0001 cacyofspeci \u0001 cantimicrobial agentshasnotbeenevaluate dintheliterature,the committeecan onlysuggestcoveragedirected by identi \u0001 edpathogenicorganisms.Onthebasis ofthe Fyshtrial,empirictherapyshouldincludetreat- mentfor S.aureus (includingmethic illin-resistant S.aureus )and P.aerugi nosa ,while broadercov- erageshouldbeconsidered,as15 otherpathogens wereidenti \u0001 edinthe 29remainingpatientswith positivecultures.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "23 Empiriccoveragef orresistant organismsshouldbebasedonbothlocalsuscepti- bilityratesand resist ancepatternsfrom known colonizationorpreviousinfections.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Thecommitteerecognizesthelackof evidence supportingempiricanaerobiccoverage.However, includingempiricanaerobiccoveragemayberea- sonablefor2reasons.First,whileanaerobic organismsmightbeinfrequentcausesofIPC-related pleuralspaceinfections,theyarecommonlyisolated in parapneumonicinfections.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "66 Sometimesitisdif- \u0001 culttodistinguishthe source ofapleuralspace infectioninthesettingofanIPC,andtheclinician shouldmakeeveryeffort torecognizeacoexisting pneumoniawhendecidingonempiricregimen.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Second,whileanaerobeswereonlyfoundin3/50 casesintheFyshtrial,thismayhavebeenan underrepresentationastheuseo fi no culatedanae- robicbloodculturebottleshasbeens hownto sig- ni \u0001 cant lyincreasedetectionofanaerobicorgan- isms.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "67 While themanuscript didnot speci \u0001 cally addressculturemethod,atthetimeofthestudy (2001-2012)thiswasnotyetstandardpractice.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Aswith complicatedparapn eumoniceffu- sions,theappropriate lengthoftherapyis unknownandlikely shouldbebas edonseverityof illness,systemicresponse,drainageadequacy.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Whetherrepeatcultureshaveany roleinguiding therapydurationisalso unknown.Decisions regardingrouteo f d eliveryandnarrowingo f coverageshouldlikelybebasedonacombination ofseverity ofillness,responsetoi ni tialtherap y, patientpreferences regardi nghospitalization, and suspicionforpresence ofresistantorganisms.",
            "Tag": "Reference"
        },
        {
            "Type": "Paragraph",
            "Text": "Thereis nodata regardingtheuseofintrapleural antimicrobials,however,wit htheIPCasaneasy methodofaccesstothepleuralspacethisisan intriguingquestionthatisworth evaluatingfurther inclinicalstudies.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Recommendation 11 InpatientswithIPCsforthemanagementof knownorsuspectedMPEswhoare receiving chemotherapy, wesuggestagainstremovingthe catheterforthepurposeofreducinginfectionrisk (UngradedConsensus-BasedStatement).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Background TheconcernoverIPCinfectioninimmuno- compromised patientsreceiving chemotherapyis reasonableas theindwellingcatheterservesasa potentialportalofentryforinfectiousorganisms.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "However,giventhepalliativebene \u0001 tofIPCs and theirpositiveimpactonfunctionalstatus,in anticipationofchemotherapyarisk-bene \u0001 t analysis is warrantedbeforedecidingonIPC removalorplacement.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "SummaryofEvidence In asinglecenter, 6-yearretrospectivereview, Mekhaieletal 19 comparedinfectionrateinMPE patientswithIPCswhowerereceivingchemo- therapyto thosewho werenot.Atotal of262IPCs in243patientswereincluded,ofwhich173IPCs J BroncholInterventPulmonol \u0001 Volume27, Number4,October2020 AABIPEvidence-informed PleuralCatheterGuidelines www.bronchology.com | 241 Downloaded from http://journals.lww.com/bronchology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 07/18/2024 (66%) wereinthechemotherapygroup.BothIPC- relatedpleuralspaceinfectionsandsofttissue infectionswereanalyzed.Theauthorsde \u0001 ned active chemotherapyaspatientshavingreceivedchemo- therapeuticagent swithin6weeksofIPC placement orat anyt imepoint duringwhichthe IPCwas insitu.Overallinfectionratewas6.1% ofwhich 3.8%wereIPC-relatedp leuralspacei nfectionsand 2.3%weresofttissueinfections.Theoveralli nfection ratein thechemotherapyarmwas5.2%compared with7.9%inthenonchemotherapyarm,as tatisti- callyinsigni \u0001 cant difference( P = 0.4).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "AsimilarstudybyHaketal 18 analyzed104 IPCpatientswithMPE,ofwhich43(41%)were receivingchemotherapy.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Therate ofinfection within6monthsofIPCinsertion was9.3% inthe chemotherapyarmversus 4.9%inthenon- chemotherapyarmwhichwasalsonotstatisti- callydifferent( P = 0.311).The6-month mortality wassigni \u0001 cantlyhigherin thosenot receiving chemotherapy,whichcan beexplainedby severityof illnessprecludingchemotherapy.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Mitchelletal 20 retrospectivelyrevieweda 10-yearcohortofpatients withIPCsplacedfor MPEs associatedwithbreastcancer.Inthisstudy theeffectofchemotherapyonIPCremovalwas theprimaryoutcome,whiledevelopmentof infectionswassecondarilyevaluated.Atotalof 207patientswereincludedofwhich104(48.2%) receivedchemotherapywithIPCinsitu.Both infectionratesandoverallrateof IPCremoval weresimilarbetweenthe2groups.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Inpatientswith hematologicmalignancies, whooften receivecytotoxicchemotherapy resultinginsigni \u0001 cantneutropenia,therealso doesnotappear tobeanincreasedinfectionrisk.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Gilbertetal 65 evaluated91suchpatientswith IPCsandfoundan8%overall rateofinfection withameancatheterdurationof90 days.While therewasnocomparisongroup,theinfection ratewassimilartothosefoundinotherreviews ofIPCinfectionsin malignantdisease.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "31 Only 43%ofpatientswerereceivingactivechemo- therapyandthespeci \u0001 cfrequencyofinfectionsin thissubgroupwasnotreported.Overallmortal- ity related toinfectionwas2%.However,ofthe 7 patientswhodiddevelopIPC-relatedinfections, 2 diedfromtheinfection(29%).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Fourofthe patientswhosurvived hadIPCsremoved, while2 of the3patientswhoseIPCs wereretaineddied.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Faizetal 44 reviewedtheratesof IPC-related infections inhematologicmalignanciesovera 14-yearperiodatasinglelarge-volume cancer center.Atotalof172 patientswith 208IPCswere analyzed.Ninepatients(5.2%)developedinfec- tiouscomplications.Of these,5(2.9%)were pleuralspaceinfections,3(1.7%)weretunnel tractinfections and1 (0.6%)wasanexit-site infection.Again,theseratesaresimilarto those discussedpreviously.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "31,32,68,69 Justi \u0001 cation forRecommendation Therisk ofIPC-related infectionsinpatients receivingchemotherapyappearstobelowacross severalsubgroupsofcancerpatients.Whilethere are noprospective,random izedtrialsassessing this question,multiplerobustre trospectivereviewsare consistentin demonstratingthese \u0001 ndings,with reportedinfectionratessi milart ot hosewithIPCs notundergoingchemotherapy.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "18 \u0152 20,44 Thecom- mittee \u0001 ndstheseresults,combinedwiththepal- liative bene \u0001 tofIPCs,compellingjusti \u0001 cationfor itsrecommendation.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "CONCLUSIONS Tothebestofourknowledgethisisthe \u0001 rst guidelinedevotedtothepostinsertionmanagement ofIPCs inpatientswithMPEs.Our goalwas to provideaframework based ontheb estavailable evidenceandwheredatawas lackingexpertopin- ion.Indeveloping ourdocument,we utilizedthe TCBSapproach, 7 whichresultsinunbiased, scienti \u0001 callyval id,standards-compliant,andtrust- worthyguidance.However,despitewhatwe cons ideredarigorousme thodologicalprocessfor synthesizing andreportingtheevidence,we acknowledgelimitationstoourrecommendations.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Allchosentopicsforevaluationwerefeltto beclinicallyimportantandpotentiallyaction- able.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "We dorecognizethatcertaintopicswere notaddressed.Someofthesetopicswereinten- tionallyavoidedduetoinabilitytode \u0001 nebest practicesorunclearrelevanceandapplicabilityto generalpractice.Examplesincludetheuseof serialexaminationsof pleuralcytology orbio- markerstoguideinterventions,andthe roleof maintainingadailydrainagelog.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Amajorlimitationof ourdocument isthelack of qualityclinicaltrialstosupport decision-making.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Mostoftheavailableevidenceiscon \u0001 nedtoretro- spectivereviews.Consequently,despiteourmeth- ods,wewere unable toprovideany guidance with strengthexceedingthatofsuggestions.Assuch,itis importanttoemphasizethatalackofstrictadher- encetotheseguidelinesshouldnotbeconsidereda devi ationfromstandardo fcare.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Nevertheless,we feelourdocumentusestheappropriateguidance MilleretalJ BroncholInterventPulmonol \u0001 Volume27, Number4,October2020 242 | www.bronchology.com Downloaded from http://journals.lww.com/bronchology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 07/18/2024 andtransparencyforthereadertodecidetherelative valueofeachrecommendation.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Wealsoconcedeseveralmethodological limitations.Inthis project,searcheswerenot peer-reviewedbyobjectivemedical librarians, andqualityassessmentsweremadebyonly1 methodologistandnotcon \u0001 rmedbydualcri- tiques.However,theauthorsbelievethattherisk ofmissingrelevantmanuscriptsbynotincluding alibrarian intheliteraturesearchislowsincethe bodyofliteraturededicatedtothemanagement ofIPCsforthemanagementofMPEsisrela- tivelysmall.Also,throughacombinationofthe PubMedsearchdevelopedbythe authorsandthe manualsearchesperformed bythepanelmem- bership(who are veryfamiliarwiththeexisting literaturewithinthe \u0001 eld),theauthorsfeelcon- \u0001 dentthattheliteraturereviewwassuf \u0001 ciently comprehensive.Whiledualqualityassessments by2methodologistsisideal,thedecisionwas madetolimit toasinglemethodologistdueto costrestraints.Giventhesmall numberofarticles whichunderwentmethodologicalassessment,all ofwhich clearlyhad high/seriousrisksofbias,the authorsdonotbelievethatthisalteredthe \u0001 nal conclusions.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Thecompositionofthe panelmembershipis anotherpotentiallimitation.Thevotingmem- bership includedonly interventionalpulmonolo- gistsandmid-levelproviderswho practiceunder thesupervisionof interventionalpulmonologists.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Thereare multipleotherproviderspecialties whichareinvolved intheplacementofIPCsfor MPEsaswellaspatientmonitoringandman- agementofcomplication,suchasthoracic sur- geons,interventionalradiologists,oncologists, andinfectiousdiseasespecialists.Consensus opinionsmighthavediffereddependingonthe distribution ofdisciplinesrepresentedbutthisis unknown.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Finally,thepaneldidnotincludeaconsumer representative,whichinthiscasewouldhave beenapatient withMPEmanagedwithanIPC.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Thisis recommendedaspartofthe TCBS developmentprotocol.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "7 However,suchaninclu- sionwasdeemedimpracticalbasedonthetime- linedevelopedfortheguidelineswhichexceeded theaveragelife-expectancyofsuchpatients.In futureupdates, whichtheauthors expectto be less time-intensive,aggressiveattemptswillbe madeto includeaconsumerrepresentative.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Ourprocess identi \u0001 edseveralareasin needof morerigorousinvestigation.Since IPCpatients withMPEstypicallyhave alimitedlifespan, requirefrequenthospitalizationsand palliative interventions,andmay have anincreased riskfor complicationssuchasinfection,focusingonthese aspects isparamount.Somespeci \u0001 ctargetsfor furtherclinicalinvestigationcouldinclude the feasibilityandef \u0001 cacyofoutpatientmanagement of IPC-relatedpleuralspaceinfections;better methods ofidentifyingfactorspredictingsuc- cessfulspontaneouspleurodesis; thevalueof combiningIPCandpleurodesisapproachesfor minimizing timetoandenhancingrateofcath- eterremoval;ormoreprecise methodsof diag- nosingIPC-relatedpleuralinfections.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Wealso encouragereexaminationofareasthathave alreadybeenaddressed,suchasvariousout- comesrelatedtoaggressiveIPCdrainagesched- ules.Theseadditionaltrialsmayhelpeither solidifyexistingevidenceorraisefurtherques- tionsbyrefuting it.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Inconclusion,these guidelineswere devel- opedtoprovidepracticaland usefulassistanceto clinicianscaring forpatientswithIPCsand MPEs.Theauthorshopethatthisdocumentnot onlyprovidesavaluabledata summaryand expert-basedopinionforthe readerbutwill stimulatefuturestudyandallowformorerobust andevidence-basedguidelinesinthefuture.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "ACKNOW LEDGMENT TheauthorsthankBelindaIreland,MD,PhD (meth- odologist),TheEvidenceDocLLC,SaintLouis, MO.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "REFERENCES 1.TaghizadehN, FortinM,TremblayA.UShospital- izationsformalignantpleuraleffusions:datafromthe 2012 National InpatientSample.",
            "Tag": "Reference"
        },
        {
            "Type": "Paragraph",
            "Text": "Chest .2017;151: 845 \u0152 854.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2.Feller-KopmanDJ, ReddyCB,DeCampMM,etal.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Managementofmalignantpleuraleffusions.anofficial ATS/STS/STRclinical practiceguideline.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "AmJRespir CritCareMed.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2018;198:839 \u0152 849.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "3.DaviesHE,MishraEK,KahanBC,etal.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Effectof an indwellingpleuralcathetervschesttubeandtalc pleurodesisforrelieving dyspneainpatientswith malignant pleuraleffusion:theTIME2randomized controlledtrial.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "JAMA.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2012;307:2383 \u0152 2389.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "4.GrahamR, MancherM, WolmanD,etal.Instituteof Medicine.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "ClinicalPracticeGuidelinesWeCan Trust.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Washington,DC:TheNationalAcademiesPress;2011.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "5.QaseemA,ForlandF, MacbethF, etal.Guidelines Internation alNetwo rk: tow ardinternation alstand ard s forclinicalpracticeguidelines.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "AnnInternMed .2012; 156:525 \u0152 531.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "6.Neumann I,SchunemannHJ.Guidelinegroups should makerecommendationseveniftheevidenceisconsid- eredinsufficient.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "CMAJ .2020;192:E23 \u0152 E24.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "J BroncholInterventPulmonol \u0001 Volume27, Number4,October2020 AABIPEvidence-informed PleuralCatheterGuidelines www.bronchology.com | 243 Downloaded from http://journals.lww.com/bronchology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 07/18/2024 7.LewisS,DiekemperR,OrnelasJ,etal.Methodologies for thedevelopment ofCHEST GuidelinesandExpert PanelReports.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Chest.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2014;146:182 \u0152 192.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "8.DiekemperRL,PatelS,MetteSA,et al.Makingthe GRADE:CHESTupdatesitsmethodology.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Chest .2 01 8; 153:756 \u0152 759.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "9.SterneJAC,Savovi \u0001 J, PageMJ,etal.RoB2:a revised toolforassessingrisk ofbiasinrandomisedtrials.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "BMJ.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2019;366:14898.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "10.SterneJAC,Hern\u00e1nMA,ReevesBC,etal.ROBINS-I: atoolfor assessingriskofbias innon-randomisedstudies ofinterventions.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "BMJ .2016;355:i4919.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "11.SpecialistUnitfor ReviewEvidence(SURE)checklist.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2018.Availableat:http://www .cardiff.ac.uk/specialist- unit-for-review-evidence/re sources/critical-appraisal- checklists.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "AccessedMarch15, 2019.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "12.WhitmanNI.TheDelphitechniqueasanalternativefor committeemeetings.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "JNurs Educ.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "1990;29:377 \u0152 379.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "13.HsuCC,SandfordBA.The Delphitechnique:making senseof consensus.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "PracAssessResEval.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2007;12:1 \u0152 8.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "14.KwongJS,ChenH,SunX.Developmentofevidence- basedrecommendations:implicationsforpreparingexpert consensusstatements.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "ChinMedJ(Engl).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2016;129: 2998 \u0152 3000.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "15.FinkA,KosecoffJ,ChassinM,etal.Consensus methods:characteristicsandguidelinesforuse.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "AmJ Public Health .1984;74:979 \u0152 983.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "16.DjulbegovicB,Guyatt G .Evidencevsconsensusinclinical practice guidelines.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "JAMA.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2019;322:725 \u0152 726.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "1 7 .VialMR,OstDE,EapenGA,etal.Intrapleuralfibrinolytic therapyinpatients withnondrainingindwellingpleural catheters.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "J Bronchology IntervPulmonol .2 01 6;23 :98 \u0152 105.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "18.HakCC,SivakumarP, AhmedL.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Safetyofindwelling pleuralcatheteruseinpatientsundergoingchemotherapy: afive-yearretrospectiveevaluation.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "BMCPulmMed.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2016;16:41.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "19.MekhaielE,KashyapR,MullonJJ,etal.Infections associatedwithtunnelledind wellingpleuralcathetersin patientsundergoingchemotherapy.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "JB ronchologyInterv Pulmonol .2013;20:299 \u0152 303.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "20.MitchellMA, Burkett A,LiP,etal.Effectof chemotherapyonremovalofindwellingpleuralcathe- tersinbreastcancerpatientswithmalignantpleural effusions.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Respiration .2018;96:552 \u0152 559.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "21.WahidiMM,ReddyC,Yarmus L,etal.Randomized trialofpleuralfluiddrainagefrequencyinpatientswith malignantpleuraleffusions.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "The ASAPTrial.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Am J RespirCritCareMed.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2017;195:1050 \u0152 1057.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "22.MuruganandanS,AzzopardiM,FitzgeraldDB,etal.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Aggressiveversussymptom-guided drainageofmalig- nantpleuraleffusionvia indwellingpleuralcatheters (AMPLE-2):anopen-labelrandomisedtrial.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Lancet RespirMed.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2018;6:671 \u0152 680.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "23.FyshETH,TremblayA,Feller-KopmanD,etal.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Clinical outcomesofindwellingpleuralcatheter-related pleuralinfections:aninternational multicenterstudy.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Chest .2013;144:1597 \u0152 1602.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "24.FyshETH,WatererGW,Kendall PA, etal.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Indwelling pleuralcathetersreduceinpatientdaysoverpleurodesisfor malignantpleuraleffusion.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Chest .2012;142:394 \u0152 400.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "25.ThomasR,FyshETH,SmithNA,etal.Effectofan indwellingpleuralcathetervstalcpleurodesison hospitalizationdaysinpatientswithmalignantpleural effusion:theamplerandomizedclinicaltrial.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "JAMA.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2017;318:1903 \u0152 1912.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "26.LanRS, LoSK,Chuang ML,etal.Elastanceofthe pleuralspace:apredictorfortheoutcomeofpleurodesis in patientswith malignantpleuraleffusion.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "AnnIntern Med.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "1997;126:768 \u0152 774.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "27.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "RobertsME,NevilleE,Berrisford R G,etal.BTS Pleural DiseaseGuidelineGrou p.Man agementofamalignan t pleural effusion: BritishThor acicSocietyPleuralDisease Guideline2010.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Thorax .2010;65(suppl2):ii32 \u0152 ii40.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "28.ChopraA,JudsonMA,DoelkenP, etal.Therelation- shipofpleuralmanometrywith postthoracentesischest radiographicfindingsinmalignantpleuraleffusion.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Chest .2020;157:421 \u0152 426.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "29.HermanDD,CooperAZ, EsguerraV.Isthe findingof anabsent \ufb01 sinusoidsign \ufb02 onlungultrasoundmean- ingful? AnnAm ThoracSoc.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2019;16:1075 \u0152 1075.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "30.EfthymiouCA,MasudiT,Thorpe JA, etal.Malignant pleuraleffusion inthepresenceoftrappedlung.Five- year experienceofPleurX tunnelledcatheters.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Interact CardiovascThoracSurg .2009;9:961 \u0152 964.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "31.LuiMM,ThomasR,LeeYC.Complicationsof indwellingpleuralcatheter useandtheirmanagement.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "BMJOpenRespirRes.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2016;3:e000123.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "32.TremblayA,MichaudG.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Single-centerexperiencewith 250tunnelledpleuralcatheterinsertionsformalignant pleuraleffusion.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Chest .2006;129:362 \u0152 368.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "33.ThomasR,PiccoloF,Miller D,etal.Intrapleural fibrinolysisforthetreatmentofindwellingpleural catheter-relatedsymptomaticloculations:amulticenter observationalstudy.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Chest .2015;148:746 \u0152 751.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "34.Pollak JS,BurdgeCM,Rosenblatt M,etal.Treatmentof malignant pleuraleffusionswith t unneled long-term drainage catheters.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "JVascIntervRadiol .2001;12:201 \u0152 208.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "35.FyshETH, WrightsonJM,LeeYCG,etal.Fractured indwellingpleuralcatheters.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Chest .2012;141:1090 \u0152 1094.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "36.WilshireCL,LouieBE,Aye RW,etal.Safetyand efficacyoffibrinolytictherapyinrestoringfunctionof anobstructedtunneledpleuralcatheter.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "AnnAmThorac Soc.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2015;12:1317 \u0152 1322.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "37.DaviesHE,Merchant S, McGownA.Astudyofthe complicationsofsmallbore \u201a Seldinger \u2122 intercostalchest drains.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Respirology.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2008;13:603 \u0152 607.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "38.PiccoloF,Popowicz N,WongD, etal.Intrapleural tissueplasminogenactivatoranddeoxyribonuclease therapyforpleuralinfection.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "JThoracDis.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2015;7:999.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "39.DaveyP,BrownE,CharaniE,etal.Interventions to improveantibioticprescribing practicesforhospitalinpa- tients.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Coch ra neDa taba seSystRev.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2013;4:CD003543.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "40.Korona-GlowniakI,LosR,Rybojad P,etal.Bacterial colonizationofpleuraldrains inpatientswithlung cancer: ananalysisofriskfactors.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "MedSciMonit.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2010;16:CR84 \u0152 CR91.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "41.DonlanRM,CostertonJW.Biofilms:survivalmecha- nismsofclinicallyrelevantmicroorganisms.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "ClinMicro- biolRev .2002;15:167 \u0152 193.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "42.SzetoCC,LiPK,JohnsonDW,etal.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "ISPDcatheter- relatedinfectionrecommendations:2017update.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Perit DialInt.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2017;37:141 \u0152 154.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "43.Cardenas-GarciaJ,FitzpatrickN,ChengGZ.The utilityofultrasound todiagnosetunnel-tract infection relatedtoindwellingpleuralcatheters.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "JBronchology Interv Pulmonol.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2018;25:248 \u0152 252.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "44.FaizSA,PathaniaP,SongJ,etal.Indwellingpleural cathetersfor patientswithhematologicmalignancies.a 14-year,single-centerexperience.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "AnnAmThoracSoc.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2017;14:976 \u0152 985.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "MilleretalJ BroncholInterventPulmonol \u0001 Volume27, Number4,October2020 244 | www.bronchology.com Downloaded from http://journals.lww.com/bronchology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 07/18/2024 45.LiPK,SzetoCC,PirainoB,etal.Peritonealdialysis- relatedinfectionsrecommendations:2010update.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Perit DialInt.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2010;30:393 \u0152 423.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "46.FrostN,Br\u00fcnger M, Ruwwe-Gl\u00f6senkamp C,etal.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Indwellingpleural cathetersformalignancy-associated pleuraleffusion:reportona singlecentre \u2122 sten yearsof experience.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "BMCPulmMed.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2019;19:232.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "47.PutnamJBJr,LightRW,RodriguezRM,etal.A randomizedcomparisonofindwelli ngpl euralcatheterand doxycyclinepleurodesisinthemanagementofmalignant pleuraleffusions.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Cancer .1999;86:1992 \u0152 1999.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "48.PutnamJB Jr,WalshGL,SwisherSG,etal.Outpatient managementofmalignantpleuraleffusionbyachronic indwellingpleural catheter.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "AnnThoracSurg .2000;69: 369 \u0152 375.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "49.PorcelJM,TorresM,PardinaM,etal.Predictorsof indwellingpleuralcatheter removalandinfection: a single-centerexperiencewith336procedures.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "JBron- chologyInterv Pulmonol.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2020;27:86 \u0152 94.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "50.BibbyAC,CliveAO,SladeGC, etal.Survivalin patients withmalignantpleural effusionswhodeveloped pleuralinfection:aretrospectivecasereviewfromsix UK centers.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Chest .2015;148:235 \u0152 241.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "51.GilbertCR,LeeHJ,AkulianJA,etal.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Aquality improvementintervention toreduceindwellingtunneled pleuralcatheterinfectionrates.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "AnnAmThoracSoc.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2015;12:847 \u0152 853.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "52.HeffnerJE, KleinJS, Hampso nC.Interventi onalmanage- mentofpleuralinfections.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Chest .2009;136:1148 \u0152 1159.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "53.DaviesHE,DaviesRJ,DaviesCW.BTSPleuralDisease GuidelineGroup.Managementofpleuralinfec tionin adults:British ThoracicSocietyPleuralDiseaseGuideline 2010.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Thorax .2010;65(suppl2):ii41 \u0152 ii53.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "54.VarelaG,Jim\u00e9nezMF,Novoa N.Portablechest drainagesystemsandoutpatientchesttubemanage- ment.",
            "Tag": "Table Data"
        },
        {
            "Type": "Paragraph",
            "Text": "ThoracSurgClin.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2010;20:421 \u0152 426.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "55.Toth JW,ReedMF,VentolaLK.Chesttube drainage devices.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "SeminRespir CritCareMed .2019;40:386 \u0152 393.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "56.Desai U,JoshiJM.Useofpigtailcatheterandurosac: numerounoforambulatorychestdrainage! LungIndia.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2018;35:395.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "57.SahnSA.Managementofcomplicatedparapneumonic effusions.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Am RevRespirDis .1993;148:813 \u0152 817.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "58.KasapogluUS,ArincS,Gungor S,etal.Prognostic factorsaffectingsurvivalinnon-smallcelllungcarci- nomapatientswithmalignantpleuraleffusions.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Clin RespirJ.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2016;10:791 \u0152 799.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "59.RahmanNM,MaskellNA,WestA,etal.Intrapleural useoftissueplasminogenactivatorandDNasein pleuralinfection.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "NEnglJMed.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2011;365:518 \u0152 526.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "60.FitzgeraldD,MuruganandanS,Uribe-BecerraJP, etal.Outcomes ofintrapleuraltissue plasminogen activator (tPA)anddeoxyribnuclease(DNase)for IPC-related pleural infection(Abstract).",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Eur RespirJ.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2019;54(suppl63):3835.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "61.WaradyBA,BakkalogluS,NewlandJ,etal.Consensus guidelinesforthe preventionandtreatmentofcatheter- relatedinfectionsandperitonitis inpediatricpatients receivingperitonealdialysis:2012update.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "PeritDialInt.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2012;32(suppl2):S32 \u0152 S86.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "62.GuptaB,BernardiniJ,PirainoB.Peritonitisassociated withexitsiteand tunnelinfections.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "AmJKidneyDis.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "1996;28:415 \u0152 419.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "63.SzetoCC,ChowKM,Leung CB,etal.Clinicalcourse of peritonitisdueto Pseudomonas speciescomplicating peritonealdialysis:areviewof104cases.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "KidneyInt.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2001;59:2309 \u0152 2315.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "64.LightRW.Pleuraleffusion.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "NEnglJMed .2002;346: 1971 \u0152 1977.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "65.GilbertCR,LeeHJ,SkalskiJH,etal.theuseof indwellingtunneledpleuralcathetersfor recurrent pleuraleffusionsinpatientswithhematologicmalig- nancies:amulticenter study.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Chest .2015;148:752 \u0152 758.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "66.MaskellNA,DaviesCW,NunnAJ,etal.U.K.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Controlledtrialofintrapleuralstreptokinaseforpleural infection.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "NEnglJMed .2005;352:865 \u0152 874.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "67.MenziesSM,RahmanNM,WrightsonJM,etal.Blood culturebottlecultureofpleural fluidinpleural infection.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Thorax.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "2011;66:658 \u0152 662.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "68.WarrenWH,KalimiR,KhodadadianLM,et al.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "Managementofmalignantpleuraleffusionsusingthe Pleur(x)catheter.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "AnnThoracSurg .2008;85:1049 \u0152 1055.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "69.SiorisT,SihvoE,SaloJ,etal.Long-termindwelling pleuralcatheter(PleurX)for malignantpleuraleffusion unsuitablefortalcpleurodesis.",
            "Tag": "Table Data"
        },
        {
            "Type": "Paragraph",
            "Text": "Eu rJSurgOn col .2009; 35:546 \u0152 551.",
            "Tag": "Paragraph"
        },
        {
            "Type": "Paragraph",
            "Text": "J BroncholInterventPulmonol \u0001 Volume27, Number4,October2020 AABIPEvidence-informed PleuralCatheterGuidelines www.bronchology.com | 245 Downloaded from http://journals.lww.com/bronchology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hC ywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 07/18/2024.",
            "Tag": "Paragraph"
        }
    ]
}